{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:57:14Z","timestamp":1790665034324,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qingdao Key Clinical Specialty Elite Discipline"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01223-y","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:33:08Z","timestamp":1789389188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multinational pharmacovigilance assessment of drug-associated esophageal ulceration and perforation: evidence from FAERS, JADER, and Canada Vigilance"],"prefix":"10.1186","volume":"27","author":[{"given":"Lihua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchi","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-1857","authenticated-orcid":false,"given":"Wensheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"8","key":"1223_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1442-2050.2009.00972.x","volume":"22","author":"GN Zografos","year":"2009","unstructured":"Zografos GN, Georgiadou D, Thomas D, Kaltsas G, Digalakis M. Drug-induced esophagitis. Dis Esophagus. 2009;22(8):633\u20137. https:\/\/doi.org\/10.1111\/j.1442-2050.2009.00972.x.","journal-title":"Dis Esophagus"},{"issue":"11","key":"1223_CR2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1345\/aph.1D056","volume":"37","author":"JL O\u2019Neill","year":"2003","unstructured":"O\u2019Neill JL, Remington TL. Drug-induced esophageal injuries and dysphagia. Ann Pharmacother. 2003;37(11):1675\u201384. https:\/\/doi.org\/10.1345\/aph.1D056.","journal-title":"Ann Pharmacother"},{"issue":"31","key":"1223_CR3","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.3748\/wjg.v20.i31.10994","volume":"20","author":"SH Kim","year":"2014","unstructured":"Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, Chang MS, Im JP, Kang HW, Shin CM. Clinical and endoscopic characteristics of drug-induced esophagitis. World J Gastroenterol. 2014;20(31):10994\u20139. https:\/\/doi.org\/10.3748\/wjg.v20.i31.10994.","journal-title":"World J Gastroenterol"},{"issue":"14","key":"1223_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1056\/nejm199610033351403","volume":"335","author":"PC de Groen","year":"1996","unstructured":"de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335(14):1016\u201321. https:\/\/doi.org\/10.1056\/nejm199610033351403.","journal-title":"N Engl J Med"},{"issue":"3","key":"1223_CR5","doi-asserted-by":"publisher","first-page":"e57043","DOI":"10.7759\/cureus.57043","volume":"16","author":"M Almayoof","year":"2024","unstructured":"Almayoof M, Abbarh S, Mohammed A, Sawaf B, Alawad MJ, Alobaidy M. Esophageal Ulceration Following the Ingestion of a Single Dose of Doxycycline: A Case Report. Cureus. 2024;16(3):e57043. https:\/\/doi.org\/10.7759\/cureus.57043.","journal-title":"Cureus"},{"issue":"4","key":"1223_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/his.14177","volume":"77","author":"SAC Medlicott","year":"2020","unstructured":"Medlicott SAC, Schell A, Medlicott JG, Adams F, Trpkov K. Doxycycline-induced spongiotic oesophagitis is associated with eosinophilic vascular degeneration. Histopathology. 2020;77(4):684\u20136. https:\/\/doi.org\/10.1111\/his.14177.","journal-title":"Histopathology"},{"issue":"3","key":"1223_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5603\/imh.2015.0035","volume":"66","author":"M Rottenstreich","year":"2015","unstructured":"Rottenstreich M, Rottenstreich M, Shapira S. Doxycycline induced oesophageal ulcers in a navy ship crewmember. Int Marit Health. 2015;66(3):181\u20133. https:\/\/doi.org\/10.5603\/imh.2015.0035.","journal-title":"Int Marit Health"},{"issue":"1","key":"1223_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12876-021-02063-2","volume":"21","author":"GM Roro","year":"2021","unstructured":"Roro GM, Folvik G, Louis L, Bane A. Drug-induced esophageal injuries with an atypical presentation mimicking acute coronary syndrome. BMC Gastroenterol. 2021;21(1):486. https:\/\/doi.org\/10.1186\/s12876-021-02063-2.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1223_CR9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s12325-023-02435-y","volume":"40","author":"AL Angelette","year":"2023","unstructured":"Angelette AL, Rando LL, Wadhwa RD, Barras AA, Delacroix BM, Talbot NC, et al. Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation. Adv Ther. 2023;40(4):1366\u201378. https:\/\/doi.org\/10.1007\/s12325-023-02435-y","journal-title":"Adv Ther"},{"key":"1223_CR10","doi-asserted-by":"publisher","first-page":"117954761988405","DOI":"10.1177\/1179547619884055","volume":"12","author":"MB Bestari","year":"2019","unstructured":"Bestari MB, Agustanti N, Abdurachman SA. Clindamycin-Induced Esophageal Injury: Is It an Underdiagnosed Entity? Clin Med Insights Case Rep. 2019;12:1179547619884055. https:\/\/doi.org\/10.1177\/1179547619884055.","journal-title":"Clin Med Insights Case Rep"},{"issue":"3","key":"1223_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jgh.13024","volume":"31","author":"Y Toya","year":"2016","unstructured":"Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, Orikasa S, Akasaka R, Chiba T, Uesugi N, Sugai T, Matsumoto T. Dabigatran-induced esophagitis: The prevalence and endoscopic characteristics. J Gastroenterol Hepatol. 2016;31(3):610\u20134. https:\/\/doi.org\/10.1111\/jgh.13024.","journal-title":"J Gastroenterol Hepatol"},{"key":"1223_CR12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291503","author":"M Okada","year":"2012","unstructured":"Okada M, Okada K. Exfoliative esophagitis and esophageal ulcer induced by dabigatran. Endoscopy. 2012;44 Suppl 2 UCTN:E23\u20134. https:\/\/doi.org\/10.1055\/s-0031-1291503.","journal-title":"Endoscopy"},{"issue":"8","key":"1223_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1055\/s-2005-870129","volume":"37","author":"S Abid","year":"2005","unstructured":"Abid S, Mumtaz K, Jafri W, Hamid S, Abbas Z, Shah HA, Khan AH. Pill-induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005;37(8):740\u20134. https:\/\/doi.org\/10.1055\/s-2005-870129.","journal-title":"Endoscopy"},{"issue":"3","key":"1223_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ajg.2009.115","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728\u201338. https:\/\/doi.org\/10.1038\/ajg.2009.115.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1223_CR15","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1038\/ajg.2010.445","volume":"105","author":"NS Abraham","year":"2010","unstructured":"Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF. ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2010;105(12):2533\u201349. https:\/\/doi.org\/10.1038\/ajg.2010.445.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1223_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4166\/kjg.2020.76.3.108","volume":"76","author":"MK Joo","year":"2020","unstructured":"Joo MK, Park CH, Kim JS, Park JM, Ahn JY, Lee BE, Lee JH, Yang HJ, Cho YK, Bang CS, Kim BJ, Jung HK, Kim BW, Lee YC. [Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition]. Korean J Gastroenterol. 2020;76(3):108\u201333. https:\/\/doi.org\/10.4166\/kjg.2020.76.3.108.","journal-title":"Korean J Gastroenterol"},{"key":"1223_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/tgh-23-44","volume":"9","author":"A Al-Dwairy","year":"2024","unstructured":"Al-Dwairy A, Azar L, Bakain T, Ahmad A, Woo S, Nithagon P, Chalhoub W. Viral esophagitis in non-human immunodeficiency virus patients: a case-control study. Transl Gastroenterol Hepatol. 2024;9:19. https:\/\/doi.org\/10.21037\/tgh-23-44.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"11","key":"1223_CR18","doi-asserted-by":"publisher","first-page":"e9565","DOI":"10.1002\/ccr3.9565","volume":"12","author":"AJ Chaudhary","year":"2024","unstructured":"Chaudhary AJ, Jamali T, Sohail A, Keller CE, Caines A, ELatrache M. Esophagitis in a post-liver transplant patient: a case of cytomegalovirus and herpes simplex virus-1 coinfection. Clin Case Rep. 2024;12(11):e9565. https:\/\/doi.org\/10.1002\/ccr3.9565.","journal-title":"Clin Case Rep"},{"issue":"9","key":"1223_CR19","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/pas.0b013e31816bf3fe","volume":"32","author":"JR Parfitt","year":"2008","unstructured":"Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367\u201372. https:\/\/doi.org\/10.1097\/pas.0b013e31816bf3fe.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"1223_CR20","doi-asserted-by":"publisher","first-page":"e45634","DOI":"10.7759\/cureus.45634","volume":"15","author":"AA Ali","year":"2023","unstructured":"Ali AA, Anasseri S, Abou-Ghaida J, Walker L, Barber T. Cytomegalovirus Esophagitis in an Immunocompromised Patient. Cureus. 2023;15(9):e45634. https:\/\/doi.org\/10.7759\/cureus.45634.","journal-title":"Cureus"},{"issue":"2","key":"1223_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.20524\/aog.2026.1042","volume":"39","author":"CC Cruz","year":"2026","unstructured":"Cruz CC, Santos M, Wali S, Mortan R, Ahuja R, Rong J, Gupta T, Lee IJ, Natha C, Vemulapalli V, Ngo S, Takigawa K, Varatharajalu K, Kennedy LB, Pabani A, Schneider BP, Kim KC, Shafi MA, Thomas AS, Wang Y. Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitis. Ann Gastroenterol. 2026;39(2):228\u201337. https:\/\/doi.org\/10.20524\/aog.2026.1042.","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"1223_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048.","journal-title":"Int J Med Sci"},{"issue":"6","key":"1223_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","volume":"47","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Nor\u00e9n GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement. Drug Saf. 2024;47(6):575\u201384. https:\/\/doi.org\/10.1007\/s40264-024-01421-9.","journal-title":"Drug Saf"},{"issue":"1","key":"1223_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","volume":"117","author":"PO Katz","year":"2022","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27\u201356. https:\/\/doi.org\/10.14309\/ajg.0000000000001538.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1223_CR25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","volume":"162","author":"LE Targownik","year":"2022","unstructured":"Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022;162(4):1334\u201342. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.247.","journal-title":"Expert Review. Gastroenterology."},{"issue":"2","key":"1223_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/pds.800","volume":"12","author":"R Gross","year":"2003","unstructured":"Gross R, Strom BL. Toward improved adverse event\/suspected adverse drug reaction reporting. Pharmacoepidemiol Drug Saf. 2003;12(2):89\u201391. https:\/\/doi.org\/10.1002\/pds.800.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1223_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136. https:\/\/doi.org\/10.1002\/pds.677.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1223_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/pds.1058","volume":"14","author":"N Moore","year":"2005","unstructured":"Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14(4):285\u20136. https:\/\/doi.org\/10.1002\/pds.1058.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1223_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","volume":"30","author":"A Bate","year":"2007","unstructured":"Bate A. Bayesian confidence propagation neural network. Drug Saf. 2007;30(7):623\u20135. https:\/\/doi.org\/10.2165\/00002018-200730070-00011.","journal-title":"Drug Saf"},{"issue":"2","key":"1223_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","volume":"82","author":"JS Almenoff","year":"2007","unstructured":"Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007;82(2):157\u201366. https:\/\/doi.org\/10.1038\/sj.clpt.6100258.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1223_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321. https:\/\/doi.org\/10.1007\/s002280050466.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1223_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3\u201310. https:\/\/doi.org\/10.1002\/pds.668.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"1223_CR33","doi-asserted-by":"publisher","first-page":"e0164309","DOI":"10.1371\/journal.pone.0164309","volume":"11","author":"S Sasaoka","year":"2016","unstructured":"Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y, Hatahira H, Fukuda A, Naganuma M, Hasegawa S, Kinosada Y, Nakamura M. Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events. PLoS ONE. 2016;11(10):e0164309. https:\/\/doi.org\/10.1371\/journal.pone.0164309.","journal-title":"PLoS ONE"},{"issue":"3","key":"1223_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2165\/00002018-200022030-00007","volume":"22","author":"D Jaspersen","year":"2000","unstructured":"Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf. 2000;22(3):237\u201349. https:\/\/doi.org\/10.2165\/00002018-200022030-00007.","journal-title":"Drug Saf"},{"issue":"6","key":"1223_CR35","doi-asserted-by":"publisher","first-page":"e13080","DOI":"10.1002\/jgh3.13080","volume":"8","author":"Z Fan","year":"2024","unstructured":"Fan Z, Khizar H, Lu J, Wang A, Xun T, Zhang X, Zhao H. From pill to pain: Alendronate-induced esophageal injury-A case report and review. JGH Open. 2024;8(6):e13080. https:\/\/doi.org\/10.1002\/jgh3.13080.","journal-title":"JGH Open"},{"issue":"23","key":"1223_CR36","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2169\/internalmedicine.47.1457","volume":"47","author":"T Naniwa","year":"2008","unstructured":"Naniwa T, Maeda T, Mizoshita T, Hayami Y, Watanabe M, Banno S, Ito R. Alendronate-induced esophagitis: possible pathogenic role of hypersensitivity to alendronate. Intern Med. 2008;47(23):2083\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.47.1457.","journal-title":"Intern Med"},{"key":"1223_CR37","doi-asserted-by":"publisher","first-page":"UCTNE383","DOI":"10.1055\/s-0030-1256735","volume":"43 Suppl 2","author":"GH Wagenvoort","year":"2011","unstructured":"Wagenvoort GH, van Mook WN, Bodelier AG. Clindamycin-induced esophageal ulceration. Endoscopy. 2011;43 Suppl 2UCTN:E383. https:\/\/doi.org\/10.1055\/s-0030-1256735.","journal-title":"Endoscopy"},{"issue":"2","key":"1223_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4321\/s1130-01082004000200008","volume":"96","author":"PA Rivera Vaquerizo","year":"2004","unstructured":"Rivera Vaquerizo PA, Santisteban L\u00f3pez Y, Blasco Colmenarejo M, Vicente Guti\u00e9rrez M, Garc\u00eda Garc\u00eda V, P\u00e9rez-Flores R. Clindamycin-induced esophageal ulcer. Rev Esp Enferm Dig. 2004;96(2):143\u20135. https:\/\/doi.org\/10.4321\/s1130-01082004000200008.","journal-title":"Rev Esp Enferm Dig"},{"issue":"1094","key":"1223_CR39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/postgradmedj-2016-134386","volume":"92","author":"M Stani\u0107 Beni\u0107","year":"2016","unstructured":"Stani\u0107 Beni\u0107 M, Karlovi\u0107 K, \u010cubrani\u0107 A. Clindamycin-induced necrotising oesophagitis. Postgrad Med J. 2016;92(1094):741. https:\/\/doi.org\/10.1136\/postgradmedj-2016-134386.","journal-title":"Postgrad Med J"},{"issue":"6","key":"1223_CR40","doi-asserted-by":"publisher","first-page":"e39920","DOI":"10.7759\/cureus.39920","volume":"15","author":"S Amin","year":"2023","unstructured":"Amin S, Munankami S, Desai P, Altomare J, Shah N. Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis. Cureus. 2023;15(6):e39920. https:\/\/doi.org\/10.7759\/cureus.39920.","journal-title":"Cureus"},{"key":"1223_CR41","doi-asserted-by":"publisher","unstructured":"Shatila M, Zhang HC, Shirwaikar Thomas A, Machado AP, Naz S, Mittal N, et al. Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events. J Immunother Cancer. 2024;12(11):e009742. https:\/\/doi.org\/10.1136\/jitc-2024-009742.","DOI":"10.1136\/jitc-2024-009742"},{"issue":"10","key":"1223_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/pds.5108","volume":"29","author":"S Hasegawa","year":"2020","unstructured":"Hasegawa S, Ikesue H, Nakao S, Shimada K, Mukai R, Tanaka M, Matsumoto K, Inoue M, Satake R, Yoshida Y, Goto F, Hashida T, Nakamura M. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database. Pharmacoepidemiol Drug Saf. 2020;29(10):1279\u201394. https:\/\/doi.org\/10.1002\/pds.5108.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"1223_CR43","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1159\/000543520","volume":"103","author":"F Tan","year":"2025","unstructured":"Tan F, Zhou L, Huang G, Li Y, Yin W, Xia H. Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database. Oncology. 2025;103(12):1147\u201359. https:\/\/doi.org\/10.1159\/000543520.","journal-title":"Oncology"},{"issue":"11","key":"1223_CR44","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/apt.17980","volume":"59","author":"MJ Townsend","year":"2024","unstructured":"Townsend MJ, Benque IJ, Li M, Grover S. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Aliment Pharmacol Ther. 2024;59(11):1350\u201365. https:\/\/doi.org\/10.1111\/apt.17980.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1223_CR45","doi-asserted-by":"publisher","first-page":"e02159","DOI":"10.14309\/crj.0000000000002159","volume":"13","author":"S Tomar","year":"2026","unstructured":"Tomar S, Jessamy K, Yang D, Hayat M. Desquamating Esophagitis in the Era of Immune Checkpoint Inhibitors: A Rare Upper Gastrointestinal Manifestation. ACG Case Rep J. 2026;13(6):e02159. https:\/\/doi.org\/10.14309\/crj.0000000000002159.","journal-title":"ACG Case Rep J"},{"key":"1223_CR46","doi-asserted-by":"publisher","first-page":"1700589","DOI":"10.3389\/fphar.2025.1700589","volume":"16","author":"S Watanabe","year":"2025","unstructured":"Watanabe S, Nagura K, Okada N, Watanabe T, Sagara H. Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases. Front Pharmacol. 2025;16:1700589. https:\/\/doi.org\/10.3389\/fphar.2025.1700589.","journal-title":"Front Pharmacol"},{"key":"1223_CR47","doi-asserted-by":"publisher","first-page":"1700587","DOI":"10.3389\/fphar.2025.1700587","volume":"16","author":"K Nagura","year":"2025","unstructured":"Nagura K, Watanabe S, Watanabe T, Sagara H. Atrial fibrillation signals associated with overactive bladder drugs across JADER and FAERS: disproportionality and time-to-onset analyses. Front Pharmacol. 2025;16:1700587. https:\/\/doi.org\/10.3389\/fphar.2025.1700587.","journal-title":"Front Pharmacol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01223-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01223-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01223-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:02:40Z","timestamp":1790661760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01223-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01223-y","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used anonymized and de-identified data from publicly available spontaneous reporting databases (FAERS, JADER, and Canada Vigilance). No individual patient identifiers were accessed. Therefore, institutional review board approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"135"}}